Page last updated: 2024-11-13
aflastatin a
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
aflastatin A: inhibitor of aflatoxin production by aflatoxigenic fungi; from Streptomyces sp.; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 54690336 |
SCHEMBL ID | 8101658 |
MeSH ID | M0274928 |
Synonyms (2)
Synonym |
---|
aflastatin a |
SCHEMBL8101658 |
Research Excerpts
Overview
Aflastatin A (1) is a specific inhibitor of aflatoxin production by Aspergillus parasiticus.
Excerpt | Reference | Relevance |
---|---|---|
"Aflastatin A (1) is a specific inhibitor of aflatoxin production by Aspergillus parasiticus. " | ( Absolute configuration of aflastatin A, a specific inhibitor of aflatoxin production by Aspergillus parasiticus. Ikeda, H; Isogai, A; Matsumori, N; Nagasawa, H; Ono, M; Sakuda, S; Suzuki, A, 2000) | 2.05 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (13)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (15.38) | 18.2507 |
2000's | 8 (61.54) | 29.6817 |
2010's | 2 (15.38) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 19.69
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (19.69) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |